cystic fibrosis

Home/Disease Specific/cystic fibrosis

Mucus is Retained in Cystic Fibrosis Patients’ Cells, Leads to Potentially Deadly Infections

Feb. 18, 2015 By: Nathan Hurst COLUMBIA, Mo. – Cystic fibrosis is a genetic disorder that affects one out of every 3,000 children in populations of Northern European descent. One of the key signs of cystic fibrosis is that mucus lining the lungs, pancreas and other organs is too sticky, which makes it difficult for the

UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy

February 13, 2015 6:00 am by Meghana Keshavan Cystic fibrosis has become the poster child for precision medicine – most new therapies are carefully tailored to a CF patient’s genetic makeup. University of North Carolina spinout Spyryx Biosciences is proposing a one-size-fits-all approach to the disease: It’s developing a peptide-based therapy that, in theory, could be effective

Misfolded proteins clump together in a surprising place

Stowers Institute for Medical Research, by Staff ~ October 16, 2014 Lay Summary of Findings Patients with Parkinson's disease, cardiovascular disease, and cystic fibrosis may have something in common: cells in their disease-affected tissues may produce misfolded proteins that are incapable of functioning normally. In the current issue of the scientific journal Cell, Stowers Institute

Research by Saint Louis University Scientists Offers Way to Disrupt Fibrosis

St. Louis University, by Nancy Solomon ~ November 11, 2013 A team of scientists that includes Saint Louis University researchers has identified a new way to intervene in the molecular and cellular cascade that causes fibrosis -- a condition where the body's natural process of forming scars for wound healing goes into overdrive and causes

Good Start Genetics touts in vitro test for cystic fibrosis

Boston Business Journal, by Patricia Resende ~ October 21, 2013 Molecular diagnostics developer Good Start Genetics Inc. last week presented positive data on its next generation sequencing technology. According to the Cambridge, Mass., company the data, from 16,500 patients presented at the American Society for Reproductive Medicine (ASRM) annual meeting on its GoodStart Select carrier

October 23rd, 2013|Categories: cystic fibrosis|Tags: , |